Wallachbeth Capital

Wallachbeth Capital company information, Employees & Contact Information

WallachBeth Capital is a leading provider of institutional execution services, providing clients with unconflicted advice and intelligent trading solutions. We employ a comprehensive process for developing and implementing sophisticated trading strategies, leveraging a combination of deep product knowledge, extensive market insight, and a consultative approach. Operating on a fully disclosed, agency-only basis, we are committed to facilitating all client needs with transparency and integrity.

Company Details

Employees
53
Founded
-
Address
185 Hudson Street,
Phone
646-237-8585
Email
in****@****eth.com
Industry
Financial Services
NAICS
Finance and Insurance
Monetary Authorities-Central Bank
HQ
Jersey City, New Jersey
Looking for a particular Wallachbeth Capital employee's phone or email?

Wallachbeth Capital Questions

News

WallachBeth Capital Announces The Closing of bioAffinity Technologies $1.8M Registered Direct Financing of Common Stock Priced At-The-Market Under Nasdaq Rules - Sahm

WallachBeth Capital Announces The Closing of bioAffinity Technologies $1.8M Registered Direct Financing of Common Stock Priced At-The-Market Under Nasdaq Rules Sahm

WallachBeth Capital Announces Closing of bioAffinity Technologies Public Offering for $4.8m - PR Newswire

WallachBeth Capital Announces Closing of bioAffinity Technologies Public Offering for $4.8m PR Newswire

$1.8M Registered Direct Offering: bioAffinity Closes 720K Shares to Fund CyPath Lung Sales - Stock Titan

$1.8M Registered Direct Offering: bioAffinity Closes 720K Shares to Fund CyPath Lung Sales Stock Titan

$1.8M Offering: bioAffinity to Sell 720,000 Shares at $2.50 to Fund CyPath® Lung Sales - Stock Titan

$1.8M Offering: bioAffinity to Sell 720,000 Shares at $2.50 to Fund CyPath® Lung Sales Stock Titan

WallachBeth Announces Pricing Of FBS Global Initial Public Offering - StreetInsider

WallachBeth Announces Pricing Of FBS Global Initial Public Offering StreetInsider

$4.8 Million Capital Raise: Cancer Detection Biotech bioAffinity Technologies Completes Public Offering - Stock Titan

$4.8 Million Capital Raise: Cancer Detection Biotech bioAffinity Technologies Completes Public Offering Stock Titan

Cancer Detection Biotech bioAffinity Technologies Raises $4.8M Through Public Offering of 1.9M Shares - Stock Titan

Cancer Detection Biotech bioAffinity Technologies Raises $4.8M Through Public Offering of 1.9M Shares Stock Titan

bioAffinity Technologies Announces Closing of $3.25 Million Offering - Business Wire

bioAffinity Technologies Announces Closing of $3.25 Million Offering Business Wire

WallachBeth Capital Announces Closing of QMMM Holdings LTD IPO - PR Newswire

WallachBeth Capital Announces Closing of QMMM Holdings LTD IPO PR Newswire

QMMM Holdings Limited Announces Closing of $8.6 Million Initial Public Offering - Stock Titan

QMMM Holdings Limited Announces Closing of $8.6 Million Initial Public Offering Stock Titan

WallachBeth Capital Announces Pricing of KindlyMD's $6.8 Million IPO - PR Newswire

WallachBeth Capital Announces Pricing of KindlyMD's $6.8 Million IPO PR Newswire

KindlyMD Announces Closing of $6.8 Million Initial Public Offering - Stock Titan

KindlyMD Announces Closing of $6.8 Million Initial Public Offering Stock Titan

Nutriband Inc. Prices $6.6 million Public Offering and Announces Uplisting to the NASDAQ Capital Market - PR Newswire

Nutriband Inc. Prices $6.6 million Public Offering and Announces Uplisting to the NASDAQ Capital Market PR Newswire

Top Wallachbeth Capital Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant